Bectas Therapeutics
Houston, US · Founded 2022 · Delaware corporation
Bectas Therapeutics is a biotech company operating in the therapeutic development space. The page features CEO Ronan O'Hagan discussing biotech industry insights, leadership, team building, and organizational culture.
Founders & leadership
JA
Jon A. BrilliantExecutive
RO
Ronan O'HaganCEO and President
RC
Ronan C. O'HaganPresident & CEO
Board
LC
Lynda ChinBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 of 2 rounds · 2022–2024
▶$5.5MraisedOct 2025 · 13 investors · BiotechnologyRule 506(b)
▶$5.5MraisedOct 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jon A. BrilliantExecutive Officer
- Ronan O'HaganExecutive Officer, Director
- Lynda ChinDirector
- Offering amount
- $10M
- Amount sold
- $5.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Cabaletta Bio3 shared keywordsCabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases. Its CABA platform and lead CARTA program center on rese-cel, an investigational CD19-CAR T cell therapy being evaluated in trials across rheumatology, neurology, and dermatology.
Beam Therapeutics3 shared keywordsBeam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases. The company works across multiple therapeutic areas to advance precision medicine treatments at the molecular level.
Companies competing with Bectas Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Bectas Therapeutics do?
- Bectas Therapeutics is a biotech company operating in the therapeutic development space. The page features CEO Ronan O'Hagan discussing biotech industry insights, leadership, team building, and organizational culture.
- How much funding has Bectas Therapeutics raised?
- Bectas Therapeutics has disclosed $5.5M raised across 1 of its 2 known rounds.
- Where is Bectas Therapeutics headquartered?
- Bectas Therapeutics is headquartered in Houston, US.